ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Hargreave Hale Aim Vct Plc

Hargreave Hale Aim Vct Plc (HHV)

32.50
0.00
(0.00%)
Closed 29 April 1:30AM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
32.50
Bid
32.00
Offer
33.00
Volume
0.00
32.50 Day's Range 32.50
32.00 52 Week Range 43.10
Market Cap
Previous Close
32.50
Open
32.50
Last Trade
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
35,936
Shares Outstanding
372,768,462
Dividend Yield
6.92%
PE Ratio
-18.36
Earnings Per Share (EPS)
-0.02
Revenue
-2.49M
Net Profit
-6.59M

About Hargreave Hale Aim Vct Plc

Sector
Investors, Nec
Industry
Investors, Nec
Headquarters
Blackpool, Gbr
Founded
-
Hargreave Hale Aim Vct Plc is listed in the Investors sector of the London Stock Exchange with ticker HHV. The last closing price for Hargreave Hale Aim Vct was 32.50p. Over the last year, Hargreave Hale Aim Vct shares have traded in a share price range of 32.00p to 43.10p.

Hargreave Hale Aim Vct currently has 372,768,462 shares in issue. The market capitalisation of Hargreave Hale Aim Vct is £121.15 million. Hargreave Hale Aim Vct has a price to earnings ratio (PE ratio) of -18.36.

HHV Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.51.56253232.5322639932.5DE
4-1.3-3.8461538461533.833.8322108233.00318256DE
12-3.3-9.2178770949735.835.8323593634.39246016DE
26-5.5-14.47368421053838.4323687435.67136535DE
52-8.3-20.343137254940.843.1322811337.31125775DE
156-40.75-55.631399317473.2573.25322430146.7107654DE
260-22.75-41.176470588255.2597321853254.39837827DE

HHV - Frequently Asked Questions (FAQ)

What is the current Hargreave Hale Aim Vct share price?
The current share price of Hargreave Hale Aim Vct is 32.50p
How many Hargreave Hale Aim Vct shares are in issue?
Hargreave Hale Aim Vct has 372,768,462 shares in issue
What is the market cap of Hargreave Hale Aim Vct?
The market capitalisation of Hargreave Hale Aim Vct is GBP 121.15M
What is the 1 year trading range for Hargreave Hale Aim Vct share price?
Hargreave Hale Aim Vct has traded in the range of 32.00p to 43.10p during the past year
What is the PE ratio of Hargreave Hale Aim Vct?
The price to earnings ratio of Hargreave Hale Aim Vct is -18.36
What is the cash to sales ratio of Hargreave Hale Aim Vct?
The cash to sales ratio of Hargreave Hale Aim Vct is -48.51
What is the reporting currency for Hargreave Hale Aim Vct?
Hargreave Hale Aim Vct reports financial results in GBP
What is the latest annual turnover for Hargreave Hale Aim Vct?
The latest annual turnover of Hargreave Hale Aim Vct is GBP -2.49M
What is the latest annual profit for Hargreave Hale Aim Vct?
The latest annual profit of Hargreave Hale Aim Vct is GBP -6.59M
What is the registered address of Hargreave Hale Aim Vct?
The registered address for Hargreave Hale Aim Vct is TALISMAN HOUSE, BOARDMANS WAY, BLACKPOOL, FY4 5FY
What is the Hargreave Hale Aim Vct website address?
The website address for Hargreave Hale Aim Vct is www.hargreaveaimvcts.co.uk
Which industry sector does Hargreave Hale Aim Vct operate in?
Hargreave Hale Aim Vct operates in the INVESTORS, NEC sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
VRSVersarien Plc
0.04p
(53.85%)
275.05M
TOMTomco Energy Plc
0.0525p
(50.00%)
70.56M
ENETEthernity Networks Ltd
0.0325p
(44.44%)
214.27M
MET1Metals One Plc
27.00p
(42.11%)
10.59M
AURRAurrigo International Plc
62.00p
(33.33%)
376.4k
NTQEnteq Technologies Plc
0.35p
(-30.00%)
10.04M
ARVArtemis Resources Limited
0.365p
(-27.00%)
14.16M
MTCMothercare Plc
2.00p
(-25.93%)
298.64k
CYANCyanconnode Holdings Plc
7.75p
(-23.27%)
4.12M
FDBKFeedback Plc
13.75p
(-21.43%)
625.81k
CHPCaledonian Holdings Plc
0.00475p
(11.76%)
5.68B
PREMPremier African Minerals Limited
0.0385p
(1.32%)
1.65B
SYMESupply@me Capital Plc
0.0034p
(-15.00%)
989.11M
EMEEmpyrean Energy Plc
0.0875p
(-18.60%)
436.4M
VRSVersarien Plc
0.04p
(53.85%)
275.05M

Discussion

View Full Feed
imafan imafan 2 minutes ago
Eeyore has spoken! AKA professed lying short. Real News: HUUUUGE ANNOUNCEMENTS of HUUUUGE ACCOMPLISHMENTS IMMINENT!!! WHALES LURKING!!!
HHSE
StockItOut StockItOut 3 minutes ago
Another SmartyPants/Quester lie, or you have a filing to support your assertion?
XERI
fuagf fuagf 3 minutes ago
LOL Figured that comment would grab you. 🙃 Qualification to mine would be, of course, unless they had firm numbers wrapped up with more security than Fort Knox. While fully appreciating the gravity you see in the situation, and though I've read little lately, still am guessing it's better t
glenn1919 glenn1919 4 minutes ago
CTMX..............................................a/h
CTMX
dia76ca dia76ca 4 minutes ago
"Blarcamesine and Anavex 3-71 are changing the paradigm for the treatment of neurodegenerative and neurodevelopmental diseases."
Nice summary georgejjl !
Paradigm shifts are very exciting but some folks see them before others!
The rest of this year will be pivotal.
2026 s
AVXL
Lykiri Lykiri 4 minutes ago
Actually, there’s a bit of confusion here. Under the old regulation, both positive and negative recommendations were referred to the CHM for review. However, the new regulation (effective after 3 April 2025) stipulates that only applications with serious concerns are now referred to the CHM. Therefo
NWBO
I-Glow I-Glow 5 minutes ago
And the Hindenburg report.- https://hindenburgresearch.com/mullen/.

Plus, TenKay was all over the preferred shares and the financials.

IG
MULN
boi568 boi568 5 minutes ago
Even if an ADL "odds ratio" claim could normally be considered disqualifying in lieu of a comparison of the means, it just seems to me irrelevant to the EMA here, since ADL itself is a not ready for prime time EMA endpoint in an early AD trial.
AVXL
dennisdave dennisdave 5 minutes ago
I agree with your points . However there were medicines last year which got approved by MHRA but NICE decided not to get them covered by NHS same day or so. Those companies would have been in discussions with NICE before MHRA approval . So not really sure it is absolutely comforting Ok interesting
NWBO
hedge_fun hedge_fun 6 minutes ago
That’s what I said, you’re smarter than……

the markets.

In your opinion of course!
TSLA
WarMachine WarMachine 6 minutes ago
I couldn't imagine making such a fool of myself every day on a public forum.
You don't need to imagine it. LOL
they are beyond clueless about what's really happening here
Explain, IN DETAIL, with PROOF to validate your claims, EXACTLY what is going on here. Or is it YOU who is
MONI
Uncle Monkey Uncle Monkey 7 minutes ago
wow! huge MAGA action today. FSR

hahaha
CBRF
Natural Trader Natural Trader 7 minutes ago
it does with high PT
exwannabe exwannabe 8 minutes ago
Impossible, they have to by law. They cant simply stop discussion because NWBO "might" get refusal.
I do not claim to know how the MHRA-NICE communications work.

But I do think I understand the NICE process well enough. They are at hold waiting for the evidence submission. Ever
NWBO
Truenorth2016 Truenorth2016 8 minutes ago
Any Dip Before News IMO is a Golden Opportunity Set-up!!!
CAVR
skitahoe skitahoe 9 minutes ago
There have been many bashers here saying that NICE wouldn't even speak to the company, and it would be next year or later before they would be able to treat patients with payment from the UK healthcare system. It seems like they're very wrong and the system may be ready for patients very shortly af
NWBO
dennisdave dennisdave 9 minutes ago
so it's your belief Linda dares not to disclose negative material news Ofcourse she will but I think they will probably do that when there is no more escape route IF there is bad news to report. The 10K left them no option had they prior to that received bad news so I am pretty sure they didn't rece
NWBO
manibiotech manibiotech 9 minutes ago
I agree with your points . However there were medicines last year which got approved by MHRA but NICE decided not to get them covered by NHS same day or so. Those companies would have been in discussions with NICE before MHRA approval . So not really sure it is absolutely comforting . Looks like the
NWBO
fwb fwb 9 minutes ago
You have issues,
find a woman
Let her HELP YOU get RIGHT... if you know what I mean
PLTR
I-Glow I-Glow 9 minutes ago
I believe there is a caveat to that provision as the company also has to be Deficienct in another listing requirement.

TK, can explain it much better as well as others.

IG
MULN
ddls ddls 9 minutes ago
4/28/25, Buy: 525,000, Neutral: 4,076,000, Sell: 11,275,500

One last day buy ask slap trade to make this junk look good.
BIEL
archilles archilles 10 minutes ago
Isn’t there a newly graduated law student recently passed the bar exam lawyer who will take on this case for experience for small pro bono fees. This should be a relatively easy to identify the bad guys and the victims. What we have here are the victim shareholders, who got ripped off, versus the
ENZC